North America Parasitology Identification Market – Industry Trends and Forecast to 2030

North America Parasitology Identification Market Analysis and Size

Parasitic diagnosis classically requires isolation of the parasite with culture, parasite expansion, and its subsequent sequence testing. Wide spread infection caused by different pathogen types classified as protozoan, helminths, and ectoparasites rise a major concern about the requirement of advanced tools for parasitic strain identification. For years many traditional identification methods have been employed for parasitic strain identification, also new advanced methods which are more accurate and sensitive have been deployed in diagnostic laboratories.

Data Bridge Market Research analyses that the North America parasitology identification market which was USD 1,967.83 in 2022, would rocket up to USD 2,969.67 Million by 2030, and is expected to undergo a CAGR of 5.3% during the forecast period. This indicates the market value. “Devices” dominates the products segment of the parasitology identification market owing to the rising R & D activities. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

North America Parasitology Identification Market Scope and Segmentation

Market Definition

The study of parasites, their hosts, and their interactions is known as parasitology. In the symbiotic relationship known as parasitism, one organism, the parasite, gains an advantage at the expense of another, the host typically an organism of a different species. The association could be harmful to the host as well.  The focus of parasitology as a biological field is not on the organism or environment under consideration but on how they live. As a result, it synthesizes knowledge from various disciplines and incorporates methods from various scientific disciplines, including cell biology, bioinformatics, biochemistry, molecular biology, immunology, genetics, evolution, and ecology. 

North America Parasitology Identification Market Dynamics

Drivers

Rapid diagnostic tool expansion fuels demand

The demand for the parasitology identification market has increased in developed and developing countries due to the rise in strategic initiatives by players worldwide to improve healthcare systems. Rapid diagnostic tools for detecting and treating infectious and parasitic diseases, rising disposable income, and parasitology identification all contribute to the growth of the parasitology identification market. The market will grow during the anticipated period due to the strategic initiative to promote parasitology identification and explore emerging markets.

Modern techniques enable market expansion

Parasite diagnosis requires parasite isolation with culture, expansion, and subsequent sequence testing. Significant concerns exist about the requirement for state-of-the-art tools for identifying parasitic strains due to the widespread infections caused by various pathogen types, such as protozoans, helminths, and ectoparasites. Numerous conventional techniques have been employed for years to identify parasitic strains. In diagnostic labs, advanced, contemporary methods that are more accurate and sensitive have also been used. Modern techniques such as MALDI-TOF MS, Rapid Diagnostic tests, and others are considered for a quick and precise diagnosis of the parasitic strain, which is expected to further boost the market.

Opportunities

Furthermore, government initiatives and technological advancements will extend profitable opportunities for the market players in the forecast period of 2023 to 2030. Additionally, rising healthcare infrastructure will is further expected to expand the market's growth rate in the future. 

Restraints/Challenges

On the other hand, the expensive detection procedures labor, and time intensive processes are expected to obstruct market growth. Also, stringent regulatory frameworks have the potential to challenge the market’s growth. Also, the lack of favorable reimbursement scenarios and technology penetration in the developing economies, and the lack of suitable infrastructure are projected to challenge the market in the forecast period of 2023-2030.

This parasitology identification market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the parasitology identification market contact Data Bridge Market Research for an Analyst Brief, our team will help you make an informed market decision to achieve market growth.

Recent Developments

• In 2020, Abbott conducted a malaria study in the Mpigi district using its most recent rapid diagnostic malaria kit and the standard test currently available on the market. Abbott's quick diagnostic test showed some ground-breaking results, with a doubled positivity rate compared to the standard test. This has improved the company's brand value in the marketplace
• In 2020, BD received approval for its automated flow cytometer system, the BD FACSDUET. By increasing accuracy and standardization from instrument to instrument and operator to operator, automation solutions for flow cytometry like the BD FACSDuetTM and BD FACSLyricTM Complete Sample-to-Answer Solution help to increase throughput and provide consistent results that clinicians rely on to guide patient care

North America Parasitology Identification Market Scope

The parasitology identification market is segmented on the basis of product, method, pathogen type, sample, stool concentration, preparation, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Products

• Consumables and Accessories
• Devices
• Polymerase Chain Reaction (PCR)
• Madd Spectrometers
• Microscopes
• Polystrainers
• Flow Cytometers
• Others

Methods

• Microscopic identification
• Fecal Identification
• Immunological Techniques
• Enzyme linked immunosorbent Assay (ELISA)
• Heamaggulutination Assay
• Others
• Morphological Identification
• Molecular Techniques
• Rapid Diagnostic Tests (RDTs)
• Maldi-TOF MS
• Others

Pathogen Type

• Protozoan
• Helminths
• Arthropods
• Tapeworm
• Ectoparast

Sample

• Feces
• Blood
• Urine
• Cerebrospinal fluid (CSF)
• Serum and Plasma
• Others

Stool Concentration and Preparation

• Concentration Technique
• Un-Concentration Technique

End User

• Diagnostic Centers
• Hospitals
• Clinics
• Ambulatory surgical centers
• Others

North America Parasitology Identification Market Regional Analysis/Insights

The parasitology identification market is analysed and market size insights and trends are provided by country, product, method, pathogen type, sample, stool concentration, and preparation, and end user as referenced above.

The countries covered in the parasitology identification market report are U.S., Canada, and Mexico.

U.S. is expected to dominate the region due to factors including rising healthcare costs, increased parasitology-related research and development, and trending diagnostic tool advancements.

The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends, and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The parasitology identification market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the parasitology identification market, the impact of technology using lifeline curves, and changes in healthcare regulatory scenarios and their impact on the parasitology identification market. The data is available for the historic period 2015-2020.

Competitive Landscape and Parasitology Identification Market Share Analysis

The parasitology identification market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, application dominance. The above data points provided are only related to the companies' focus related to parasitology identification market.

Some of the major players operating in the parasitology identification market are:

• Abbott (U.S.)
• BD (U.S.)
• bioMérieux SA (France)
• Bruker (U.S.)
• Quest Diagnostics Incorporated (U.S.)
• Thermo Fisher Scientific Inc.(U.S.)
• Trinity Biotech (Ireland)
• Biomerica, Inc. (U.S.)
• Bio-Rad Laboratories, Inc.(U.S.)
• Creative Diagnostics (U.S.)
• Luminex Corporation (U.S.)
• Meridian Bioscience, Inc.(U.S.)
• ORGENTEC Diagnostika GmbH (Germany)
• R-Biopharm AG (Germany)
• Shimadzu Corporation (Japan)
• Tecan Trading AG (Switzerland)
• VWR International, LLC (a subsidiary of Avantor, Inc.)(U.S.)
• Liferiver Bio-Tech (United States) Corp.(U.S.)
• altona Diagnostics GmbH (Germany)

SKU-44735